Bronchiolitis obliterans organizing pneumonia simulating progression in bronquioloalveolar carcinoma

Clinical and Translational Oncology

Volumn 8, Issue 2, 2006, Pages 133-135

  Dols, Manuel Cobo ^a   Calle, Silvia Gil ^a   Díaz, Inmaculada Alés ^a   Chamorro, Ester Villar ^a   García, Julia Alcaide ^a   Calderón, Vanesa Gutiérrez ^a   Orgaz, Manuel Benavides ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Bronchiolitis obliterans; Bronquioloalveolar carcinoma; Chemotherapy

Indexed keywords

CEFEPIME; CLARITHROMYCIN; DOCETAXEL; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GEMCITABINE; LEVOFLOXACIN; MESSENGER RNA; METHYLPREDNISOLONE; OXYGEN; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; TAXOID;

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOSCOPY; CANCER GROWTH; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CYANOSIS; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG MEGADOSE; DYSPNEA; FEVER; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; HYPOXEMIA; LUNG ALVEOLUS CELL CARCINOMA; LUNG INFECTION; LUNG INFILTRATE; MALE; MEDIASTINUM LYMPH NODE; MULTIPLE CYCLE TREATMENT; OXYGEN SATURATION; PROGNOSIS; RESPIRATORY FAILURE; SMOKING; SPUTUM; TACHYPNEA; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; LUNG TUMOR; MIDDLE AGED; RADIOGRAPHY;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; DEOXYCYTIDINE; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; LUNG NEOPLASMS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; RESPIRATORY INSUFFICIENCY; TAXOIDS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33646844980     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-006-0171-0     Document Type: Article

References (10)

1. Travis D, Garg K, Franklin W, et al. Evolving Concepts in the Pathology and Computed Tomography Imaging of Lung Adenocarcinoma and Bronchioloalveolar Carcinoma. Journal of Clinical Oncology. 2005;23(14):3279-87.
2. Schiller JH, Harrington D, Belani C, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002;346:92-8.
3. Rosell R, Tarón M, Ariza A. Molecular predictors of response to chemotherapy in Lung Cancer. Sem Oncol. 2004;31:20-7.
4. Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med. 1985;312:152-8.
5. Mokhtari M, Bach PB, Tietjen PA, Stover DE. Bronchiolitis obliterans organizing pneumonia in cancer: A case series. Respir Med. 2002;96(4):280-6.
6. Takigawa N, Segawa Y, Saeki T, et al. Bronchiolitis obliterans organizing pneumonia syndrome in breast-conserving-therapy for early breast cancer: Radiation-induced lung toxicity. Int J Radiat Oncol Biol Phys. 2000;48(3):751-5.
7. Battistini E, Dini G, Savioli C, et al. Bronchiolitis obliterans organizing pneumonia in three children with acute leukaemias treated with cytosine arabinoside and anthracyclines. Eur Respir J 1997;10(5):1187-90.
8. Edgerton CC, Gilman M, Roth BJ. Topotecan-induced bronchiolitis. South Med J. 2004;97(7):699-701.
9. Pavlakis N, Bell DR, Millward MJ, Levi JA. Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer. 1997;80:286-91.
10. Bujanda DA, Morales JA, Sarmiento A. Bronchiolitis Obliterans Organizing Pneumonia Induced by Chemotherapy. Arch bronconeumol. 2004;40:290.